QQQ   432.08 (+0.24%)
AAPL   168.99 (-2.14%)
MSFT   416.62 (+0.72%)
META   502.78 (+0.51%)
GOOGL   155.07 (+0.14%)
AMZN   184.26 (+0.35%)
TSLA   156.93 (-2.82%)
NVDA   871.31 (+1.31%)
AMD   163.45 (+1.95%)
NIO   3.83 (-1.54%)
BABA   69.45 (-1.66%)
T   16.08 (-0.99%)
F   12.13 (-0.82%)
MU   121.05 (-0.26%)
GE   155.16 (+0.95%)
CGC   7.04 (+0.86%)
DIS   114.29 (+1.19%)
AMC   2.70 (+9.31%)
PFE   25.88 (-0.12%)
PYPL   64.12 (+0.96%)
XOM   119.06 (-0.52%)
QQQ   432.08 (+0.24%)
AAPL   168.99 (-2.14%)
MSFT   416.62 (+0.72%)
META   502.78 (+0.51%)
GOOGL   155.07 (+0.14%)
AMZN   184.26 (+0.35%)
TSLA   156.93 (-2.82%)
NVDA   871.31 (+1.31%)
AMD   163.45 (+1.95%)
NIO   3.83 (-1.54%)
BABA   69.45 (-1.66%)
T   16.08 (-0.99%)
F   12.13 (-0.82%)
MU   121.05 (-0.26%)
GE   155.16 (+0.95%)
CGC   7.04 (+0.86%)
DIS   114.29 (+1.19%)
AMC   2.70 (+9.31%)
PFE   25.88 (-0.12%)
PYPL   64.12 (+0.96%)
XOM   119.06 (-0.52%)
QQQ   432.08 (+0.24%)
AAPL   168.99 (-2.14%)
MSFT   416.62 (+0.72%)
META   502.78 (+0.51%)
GOOGL   155.07 (+0.14%)
AMZN   184.26 (+0.35%)
TSLA   156.93 (-2.82%)
NVDA   871.31 (+1.31%)
AMD   163.45 (+1.95%)
NIO   3.83 (-1.54%)
BABA   69.45 (-1.66%)
T   16.08 (-0.99%)
F   12.13 (-0.82%)
MU   121.05 (-0.26%)
GE   155.16 (+0.95%)
CGC   7.04 (+0.86%)
DIS   114.29 (+1.19%)
AMC   2.70 (+9.31%)
PFE   25.88 (-0.12%)
PYPL   64.12 (+0.96%)
XOM   119.06 (-0.52%)
QQQ   432.08 (+0.24%)
AAPL   168.99 (-2.14%)
MSFT   416.62 (+0.72%)
META   502.78 (+0.51%)
GOOGL   155.07 (+0.14%)
AMZN   184.26 (+0.35%)
TSLA   156.93 (-2.82%)
NVDA   871.31 (+1.31%)
AMD   163.45 (+1.95%)
NIO   3.83 (-1.54%)
BABA   69.45 (-1.66%)
T   16.08 (-0.99%)
F   12.13 (-0.82%)
MU   121.05 (-0.26%)
GE   155.16 (+0.95%)
CGC   7.04 (+0.86%)
DIS   114.29 (+1.19%)
AMC   2.70 (+9.31%)
PFE   25.88 (-0.12%)
PYPL   64.12 (+0.96%)
XOM   119.06 (-0.52%)

Eiger BioPharmaceuticals (EIGR) SEC Filings & 10K Form

$1.72
-0.18 (-9.21%)
(As of 04/10/2024)

Recent Eiger BioPharmaceuticals SEC Filings

DateFilerForm TypeView
04/08/2024
4:19 PM
Eiger BioPharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/01/2024
3:45 PM
Eiger BioPharmaceuticals (Filer)
Form S-8 POS
04/01/2024
3:45 PM
Eiger BioPharmaceuticals (Filer)
Form S-8 POS
04/01/2024
3:48 PM
Eiger BioPharmaceuticals (Filer)
Form S-8 POS
04/01/2024
3:48 PM
Eiger BioPharmaceuticals (Filer)
Form S-8 POS
04/01/2024
3:50 PM
Eiger BioPharmaceuticals (Filer)
Form S-8 POS
04/01/2024
3:51 PM
Eiger BioPharmaceuticals (Filer)
Form S-8 POS
04/01/2024
3:53 PM
Eiger BioPharmaceuticals (Filer)
Form S-8 POS
04/01/2024
3:18 PM
Eiger BioPharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
9:55 AM
AMERIPRISE FINANCIAL INC (Filed by)
Eiger BioPharmaceuticals (Subject)
Form SC 13G/A
01/08/2024
6:00 AM
Eiger BioPharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
7:45 AM
Eiger BioPharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2023
5:01 AM
Arkin Moshe (Filed by)
Eiger BioPharmaceuticals (Subject)
Form SC 13D/A
12/01/2023
3:02 PM
Eiger BioPharmaceuticals (Filer)
Form PRE 14A
11/24/2023
5:01 AM
Arkin Moshe (Filed by)
Eiger BioPharmaceuticals (Subject)
Form SC 13D
11/02/2023
8:54 PM
Eiger BioPharmaceuticals (Subject)
Propel Bio Management, LLC (Filed by)
Form SC 13D/A
11/02/2023
8:21 PM
Eiger BioPharmaceuticals (Issuer)
KAYNE RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
8:14 PM
Eiger BioPharmaceuticals (Issuer)
KAWAS LEEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2023
3:51 PM
Eiger BioPharmaceuticals (Issuer)
KAWAS LEEN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/20/2023
3:29 PM
Eiger BioPharmaceuticals (Subject)
Propel Bio Management, LLC (Filed by)
Form SC 13D
09/28/2023
3:54 PM
Eiger BioPharmaceuticals (Subject)
Propel Bio Management, LLC (Filed by)
Form SC 13G/A
09/12/2023
3:42 PM
Eiger BioPharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2023
8:35 PM
Choong Ingrid (Reporting)
Eiger BioPharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/05/2023
8:38 PM
Choong Ingrid (Reporting)
Eiger BioPharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
5:00 AM
Eiger BioPharmaceuticals (Subject)
Propel Bio Management, LLC (Filed by)
Form SC 13G
07/07/2023
3:35 PM
BlackRock Inc. (Filed by)
Eiger BioPharmaceuticals (Subject)
Form SC 13G/A
07/06/2023
4:37 PM
Apelian David (Reporting)
Eiger BioPharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2023
3:16 PM
Eiger BioPharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2023
3:30 PM
Eiger BioPharmaceuticals (Issuer)
Vollins James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2023
3:37 PM
Eiger BioPharmaceuticals (Filer)
Form DEF 14A
04/26/2023
3:38 PM
Eiger BioPharmaceuticals (Filer)
Form DEFA14A
04/26/2023
3:39 PM
Eiger BioPharmaceuticals (Filer)
Form ARS
04/18/2023
8:59 AM
Arkin Moshe (Filed by)
Eiger BioPharmaceuticals (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:EIGR) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners